{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:58:12Z","timestamp":1774360692671,"version":"3.50.1"},"reference-count":141,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,3]],"date-time":"2016-01-03T00:00:00Z","timestamp":1451779200000},"content-version":"vor","delay-in-days":6180,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jada.ada.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of the American Dental Association"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.14219\/jada.archive.1999.0173","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T21:27:00Z","timestamp":1389216420000},"page":"236-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["ADVERSE DRUG INTERACTIONS IN DENTAL PRACTICE"],"prefix":"10.1016","volume":"130","author":[{"given":"ELLIOT V.","family":"HERSH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14219\/jada.archive.1999.0173_bib1","first-page":"47","article-title":"Adverse drug interactions in dental practice: professional and educational implications","volume":"130","author":"Moore","year":"1999","journal-title":"JADA"},{"key":"10.14219\/jada.archive.1999.0173_bib2","series-title":"Drug interactions","author":"Stockley","year":"1996"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archinte.1951.03810100073006","article-title":"Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin","volume":"88","author":"Lepper","year":"1951","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib4","first-page":"545","article-title":"Pneumococcal meningitis in the adult: clinical, therapeutic, and prognostic aspects in forty-three patients","volume":"55","author":"Olson","year":"1961","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.14219\/jada.archive.1999.0173_bib5","first-page":"694","article-title":"Penicillin and erythromycin singly and in combination in scarlatina therapy and the interference between them","volume":"11","author":"Strom","year":"1961","journal-title":"Antibiot Chemother"},{"issue":"12","key":"10.14219\/jada.archive.1999.0173_bib6","first-page":"1228","article-title":"Synergism and antagonism between antibiotic medicines containing erythromycin","volume":"4","author":"Manten","year":"1954","journal-title":"Antibiot Chemother"},{"issue":"9","key":"10.14219\/jada.archive.1999.0173_bib7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-116-9-705","article-title":"Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric and duodenal ulcer","volume":"116","author":"Graham","year":"1992","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib8","first-page":"9","article-title":"Experimental study of factors inhibiting absorption and effective therapeutic levels of declomycin","volume":"114","author":"Scheiner","year":"1962","journal-title":"Surg Gynec Obstet"},{"issue":"734","key":"10.14219\/jada.archive.1999.0173_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/bmj.4.5734.532","article-title":"Interference of iron with the absorption of tetracyclines in man","volume":"4","author":"Neuvonen","year":"1970","journal-title":"Br Med J"},{"key":"10.14219\/jada.archive.1999.0173_bib10","first-page":"76","article-title":"Interference of iron and milk with absorption of tetracycline","volume":"27","author":"Neuvonen","year":"1971","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0190-9622(85)80041-4","article-title":"Absorption of minocycline hydrochloride and tetracycline hydrochloride. effects of food, milk and iron","volume":"12","author":"Leyden","year":"1985","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3181\/00379727-73-17579","article-title":"Reduced absorption of Aureomycin caused by aluminum hydroxide gel (Amphogel)","volume":"73","author":"Waisbren","year":"1956","journal-title":"Proc Soc Exp Biol Med NY"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib13","first-page":"464","article-title":"The effect of magnesium sulfate in lowering tetracycline blood levels","volume":"50","author":"Harcourt","year":"1957","journal-title":"J Lab Clin Med"},{"issue":"5","key":"10.14219\/jada.archive.1999.0173_bib14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/jps.2600680518","article-title":"Decreased tetracycline bioavailability caused by a bismuth subsalicylate antidiarrheal mixture","volume":"68","author":"Albert","year":"1979","journal-title":"J Pharm Sci"},{"issue":"2\/3","key":"10.14219\/jada.archive.1999.0173_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00614009","article-title":"Effect of zinc sulphate on the absorption of tetracycline and doxycycline in man","volume":"9","author":"Pentilla","year":"1975","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"10.14219\/jada.archive.1999.0173_bib16","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/0006-2952(66)90100-6","article-title":"The effect of Flagyl on xanthine oxidase and alcohol dehydrogenase","volume":"15","author":"Fried","year":"1966","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib17","first-page":"147","article-title":"Preliminary report of the therapeutic effect of Flagyl in alcoholism","volume":"95","author":"Ban","year":"1966","journal-title":"Union Med Can"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib18","first-page":"43","article-title":"Evaluation of metronidazole in the treatment of alcoholism: a comprehensive three-year study comprising 60 cases","volume":"67","author":"Sansoy","year":"1970","journal-title":"Rocky Mt Med J"},{"issue":"8","key":"10.14219\/jada.archive.1999.0173_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1176\/ajp.125.8.1063","article-title":"Metronidazole in the treatment of alcoholism","volume":"125","author":"Penick","year":"1969","journal-title":"Am J Psychiatry"},{"key":"10.14219\/jada.archive.1999.0173_bib20","series-title":"Physicians&apos; desk reference","first-page":"2738","year":"1998"},{"key":"10.14219\/jada.archive.1999.0173_bib21","series-title":"Basic and clinical pharmacology","first-page":"464","article-title":"Antipsychotic agents and lithium","author":"Potter","year":"1998"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib22","first-page":"15","article-title":"Metronidazole-induced lithium intoxication","volume":"17","author":"Ayd","year":"1982","journal-title":"Int Drug Ther News"},{"issue":"24","key":"10.14219\/jada.archive.1999.0173_bib23","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1001\/jama.1987.03390240071024","article-title":"Possible nephrotoxic interaction of lithium and metronidazole","volume":"257","author":"Teicher","year":"1987","journal-title":"JAMA"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2133.1982.tb00911.x","article-title":"Cutaneous manifestations of lithium toxicity","volume":"106","author":"Heng","year":"1982","journal-title":"Br J Dermatol"},{"issue":"6121","key":"10.14219\/jada.archive.1999.0173_bib25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.1.6121.1183","article-title":"Lithium carbonate and tetracycline interaction","volume":"1","author":"McGennis","year":"1978","journal-title":"Br Med J"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2133.1982.tb00371.x","article-title":"Lithium and tetracycline","volume":"107","author":"Jefferson","year":"1982","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib27","first-page":"314","article-title":"Evaluation of lithium-tetracycline interaction","volume":"7","author":"Fankhauser","year":"1988","journal-title":"Clin Pharm"},{"key":"10.14219\/jada.archive.1999.0173_bib28","series-title":"Basic and clinical pharmacology","first-page":"197","article-title":"Cardiac glycosides and other drugs used in congestive heart failure","author":"Katzung","year":"1998"},{"issue":"14","key":"10.14219\/jada.archive.1999.0173_bib29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJM198110013051403","article-title":"Inactivation of digoxin by the gut flora: reversal by antibiotic therapy","volume":"305","author":"Lindenbaum","year":"1981","journal-title":"N Engl J Med"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1378\/chest.82.2.202-b","article-title":"Erythromycin-induced digoxin toxicity","volume":"82","author":"Friedman","year":"1982","journal-title":"Chest"},{"issue":"6673","key":"10.14219\/jada.archive.1999.0173_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.298.6673.572","article-title":"Digoxin toxicity due to interaction of digoxin with erythromycin","volume":"298","author":"Maxwell","year":"1989","journal-title":"Br Med J"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib32","first-page":"517A","article-title":"Effect of antibiotic therapy on digoxin metabolism","volume":"30","author":"Dobkin","year":"1982","journal-title":"Clin Res"},{"issue":"12","key":"10.14219\/jada.archive.1999.0173_bib33","first-page":"1620","article-title":"Potentiation of warfarin by tetracycline","volume":"37","author":"Westfall","year":"1980","journal-title":"Am J Hosp Pharm"},{"issue":"9","key":"10.14219\/jada.archive.1999.0173_bib34","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/106002809202600906","article-title":"Enhanced anticoagulant effect of coumarin derivatives induced by doxycycline coadministration","volume":"26","author":"Caraco","year":"1992","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5694\/j.1326-5377.1989.tb136404.x","article-title":"Antibiotic induced potentiation of oral anticoagulant agents","volume":"150","author":"O&apos;Donnell","year":"1989","journal-title":"Med J Aust"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/000331976501600105","article-title":"The effect of bowel sterilizing antibiotics on blood coagulation mechanisms","volume":"16","author":"Messinger","year":"1965","journal-title":"Angiology"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000204457","article-title":"Probable acenocoumarol-amoxycillin interaction","volume":"90","author":"Soto","year":"1993","journal-title":"Acta Haematol"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/jama.1965.03090150019004","article-title":"Human sources and absorption of vitamin K in relation to anticoagulant stability","volume":"194","author":"Udall","year":"1965","journal-title":"JAMA"},{"issue":"9","key":"10.14219\/jada.archive.1999.0173_bib39","first-page":"880","article-title":"Unexpected vitamin K deficiency in hospitalized patients","volume":"109","author":"Pineo","year":"1973","journal-title":"Can Med Assoc J"},{"issue":"7","key":"10.14219\/jada.archive.1999.0173_bib40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archinte.1980.00040020985027","article-title":"Possible warfarin-erythromycin interaction","volume":"140","author":"Bartle","year":"1980","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.14219\/jada.archive.1999.0173_bib41","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/archinte.1983.00350090213048","article-title":"Erythromycin-warfarin interaction","volume":"143","author":"Husseri","year":"1983","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.14219\/jada.archive.1999.0173_bib42","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/archinte.1984.04400010221042","article-title":"Erythromycin-warfarin interaction","volume":"144","author":"Schwartz","year":"1984","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.14219\/jada.archive.1999.0173_bib43","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1984.00350220145031","article-title":"Warfarin interaction with erythromycin","volume":"144","author":"Sato","year":"1984","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.14219\/jada.archive.1999.0173_bib44","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/00007611-198508000-00037","article-title":"Suspected interaction: warfarin and erythromycin","volume":"78","author":"Hassell","year":"1985","journal-title":"South Med J"},{"issue":"9","key":"10.14219\/jada.archive.1999.0173_bib45","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/archinte.1985.00360090212038","article-title":"Warfarin-erythromycin interaction","volume":"145","author":"Bussey","year":"1985","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.14219\/jada.archive.1999.0173_bib46","first-page":"782","article-title":"A significant interaction between metronidazole and warfarin","volume":"51","author":"Kazmier","year":"1976","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000137958","article-title":"The effect of erythromycin on the disposition kinetics of warfarin","volume":"28","author":"Bachmann","year":"1984","journal-title":"Pharmacology"},{"issue":"7","key":"10.14219\/jada.archive.1999.0173_bib48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJM197608122950702","article-title":"The stereoselective interaction of warfarin and metronidazole in man","volume":"295","author":"O&apos;Reilly","year":"1976","journal-title":"N Engl J Med"},{"key":"10.14219\/jada.archive.1999.0173_bib49","series-title":"Pharmacology and therapeutics for dentistry","year":"1998"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib50","first-page":"107","article-title":"Cytochrome P450: new nomenclature and clinical implications","volume":"57","author":"Cupp","year":"1998","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib51","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/j.1875-9114.1998.tb03830.x","article-title":"Update: clinically significant cytochrome P-450 drug interactions","volume":"18","author":"Michalets","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.14219\/jada.archive.1999.0173_bib52","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.1993.03500120070028","article-title":"Mechanism of cardiotoxic action of terfenadine","volume":"269","author":"Woosley","year":"1993","journal-title":"JAMA"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1742-1241.1988.tb08578.x","article-title":"Torsades de pointes ventricular tachycardia associated with astemizole overdose","volume":"42","author":"Snook","year":"1988","journal-title":"Br J Clin Pract"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/clpt.1992.135","article-title":"Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin","volume":"52","author":"Honig","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib55","first-page":"161","article-title":"Effect of erythromycin, clarithromycin and azithromycin on pharmacokinetics of terfenadine","volume":"53","author":"Honig","year":"1993","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/106002809402800226","article-title":"Drug-induced torsades de pointes: a possible interaction of terfenadine and erythromycin","volume":"28","author":"Biglin","year":"1994","journal-title":"Ann Pharmacother"},{"issue":"23","key":"10.14219\/jada.archive.1999.0173_bib57","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/archinte.1993.00410230129016","article-title":"Torsades de pointes associated with astemizole (Hismanal) therapy","volume":"153","author":"Goss","year":"1993","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199427010-00001","article-title":"Inhibition of terfenadine metabolism: pharmacokinetic and pharmacodynamic consequences","volume":"27","author":"Krvisto","year":"1994","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"10.14219\/jada.archive.1999.0173_bib59","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/jama.1993.03500120051025","article-title":"Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences","volume":"269","author":"Honig","year":"1993","journal-title":"JAMA"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib60","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199607253350416","article-title":"Cisapride and fatal arrhythmia","volume":"335","author":"Wysowski","year":"1996","journal-title":"N Engl J Med"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib61","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0272-6386(97)90291-2","article-title":"Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin","volume":"30","author":"Sekkarie","year":"1997","journal-title":"Am J Kid Dis"},{"key":"10.14219\/jada.archive.1999.0173_bib62","first-page":"1308","volume":"52","year":"1998"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib63","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00000542-199009000-00035","article-title":"Prolonged alfentanil effect following erythromycin administration","volume":"73","author":"Bartkowski","year":"1990","journal-title":"Anesthesiology"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/clpt.1989.112","article-title":"Inhibition of alfentanil metabolism by erythromycin","volume":"46","author":"Bartkowski","year":"1989","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib65","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/clpt.1990.95","article-title":"Pharmacokinetic evaluation of erythromycin and caffeine administered with bromocriptine","volume":"47","author":"Nelson","year":"1990","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib66","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/clpt.1983.62","article-title":"Effect of erythromycin on carbamazepine kinetics","volume":"33","author":"Wong","year":"1983","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.14219\/jada.archive.1999.0173_bib67","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.1986.03370090087026","article-title":"Carbamazepine-erythromycin interaction: case studies and clinical significance","volume":"255","author":"Wroblewski","year":"1986","journal-title":"JAMA"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib68","first-page":"951","article-title":"Heart block secondary to erythromycin-induced carbamazepine toxicity","volume":"80","author":"Macnab","year":"1987","journal-title":"Pediatrics"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib69","first-page":"489","article-title":"Clarithromycin-carbamazepine interaction in a clinical setting","volume":"7","author":"O&apos;Connor","year":"1994","journal-title":"J Am Board Fam Pract"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1528-1157.1993.tb02391.x","article-title":"Clarithromycin-carbamazepine interaction: a case report","volume":"34","author":"Albani","year":"1993","journal-title":"Epilepsia"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib71","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00007890-199102000-00018","article-title":"Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients","volume":"51","author":"First","year":"1991","journal-title":"Transplantation"},{"key":"10.14219\/jada.archive.1999.0173_bib72","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(82)90851-0","article-title":"Ketoconazole, cyclosporin metabolism and renal transplantation","volume":"ii","author":"Ferguson","year":"1982","journal-title":"Lancet"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0009-9236(95)90067-5","article-title":"The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine","volume":"58","author":"Gomez","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib74","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007890-199409270-00016","article-title":"The interaction between clarithromycin and cyclosporine in kidney transplant recipients","volume":"58","author":"Ferrari","year":"1994","journal-title":"Transplantation"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00007890-198702000-00020","article-title":"Exacerbation of cyclosporine toxicity by concomitant administration of erythromycin","volume":"43","author":"Jensen","year":"1987","journal-title":"Transplantation"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib76","first-page":"776","article-title":"Cyclosporin-erythromycin interaction in normal subjects","volume":"23","author":"Freeman","year":"1987","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib77","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0190-9622(95)90040-3","article-title":"Itraconazole interacts with felodipine","volume":"33","author":"Neuvonen","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib78","first-page":"165","article-title":"Marked effects of both erythromycin and grapefruit juice on felodipine pharmacokinetics","volume":"55","author":"Bailey","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib79","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/clpt.1986.114","article-title":"Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion","volume":"39","author":"Glynn","year":"1986","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib80","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/clpt.1989.42","article-title":"Impact of ketoconazole on the metabolism of prednisolone","volume":"45","author":"Zurcher","year":"1989","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib81","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0091-6749(83)90049-0","article-title":"Inhibition of methylprednisolone elimination in the presence of erythromycin therapy","volume":"72","author":"LaForce","year":"1983","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.14219\/jada.archive.1999.0173_bib82","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/arrd.1983.127.5.581","article-title":"The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis","volume":"127","author":"Reisz","year":"1983","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib83","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1542\/peds.59.1.144","article-title":"Erythromycin&apos;s effects on theophylline blood levels","volume":"59","author":"Cummins","year":"1977","journal-title":"Pediatr"},{"issue":"2\/3","key":"10.14219\/jada.archive.1999.0173_bib84","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/j.1552-4604.1982.tb02659.x","article-title":"The effects of erythromycin on theophylline elimination in normal males","volume":"22","author":"May","year":"1982","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.14219\/jada.archive.1999.0173_bib85","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/clpt.1981.84","article-title":"Effect of erythromycin base on theophylline kinetics","volume":"29","author":"Zarowitz","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib86","first-page":"213","article-title":"Rhabdomyolysis associated with lovastatin and erythromycin use","volume":"154","author":"Spach","year":"1991","journal-title":"West J Med"},{"issue":"10","key":"10.14219\/jada.archive.1999.0173_bib87","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJM199509073331015","article-title":"Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole","volume":"333","author":"Lees","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib88","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0009-9236(96)90167-8","article-title":"Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid","volume":"60","author":"Neuvonen","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib89","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/bja\/65.6.826","article-title":"Unconsciousness associated with midazolam and erythromycin","volume":"65","author":"Hiller","year":"1990","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib90","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/clpt.1993.25","article-title":"A potentially hazardous interaction between erythromycin and midazolam","volume":"53","author":"Olkkola","year":"1993","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib91","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0773.1993.tb01560.x","article-title":"Oral single doses of erythromycin and roxithromycin may increase the effects of midazolam on human performance","volume":"73","author":"Mattila","year":"1993","journal-title":"Pharmacol Toxicol"},{"issue":"5","key":"10.14219\/jada.archive.1999.0173_bib92","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004714-198610000-00008","article-title":"A pharmacokinetic interaction between erythromycin and triazolam","volume":"6","author":"Phillips","year":"1986","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"10.14219\/jada.archive.1999.0173_bib93","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/clpt.1994.60","article-title":"Midazolam should be avoided in patients receiving systemic antimycotics ketoconazole or itraconzaole","volume":"55","author":"Olkkola","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib94","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/clpt.1994.184","article-title":"Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole","volume":"56","author":"Varhe","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.14219\/jada.archive.1999.0173_bib95","first-page":"95","article-title":"Fexofenadine","volume":"38","author":"Abramowicz","year":"1996","journal-title":"Med Lett Drugs Ther"},{"issue":"7","key":"10.14219\/jada.archive.1999.0173_bib96","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinte.1995.00430070125014","article-title":"Long QT syndrome during high-dose cisapride","volume":"155","author":"Bran","year":"1995","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib97","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00193477","article-title":"Azithromycin does not alter the effects of oral midazolam on human performance","volume":"47","author":"Mattila","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.14219\/jada.archive.1999.0173_bib98","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0278-2391(92)90061-4","article-title":"Oral benzodiazepines and conscious sedation: a review","volume":"50","author":"Loeffler","year":"1992","journal-title":"J Oral Maxillofac Surg"},{"key":"10.14219\/jada.archive.1999.0173_bib99","series-title":"Basic and clinical pharmacology","first-page":"653","article-title":"The gonadal hormones and inhibitors","author":"Goldfien","year":"1998"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1902\/jop.1985.56.1.18","article-title":"Inhibition of oral contraceptive effectiveness by concurrent antibiotic administration","volume":"56","author":"Barnett","year":"1985","journal-title":"J Periodontol"},{"issue":"5","key":"10.14219\/jada.archive.1999.0173_bib101","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0190-9622(97)80322-2","article-title":"Oral contraceptive failure rates and oral antibiotics","volume":"36","author":"Helms","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib102","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00001703-199208000-00002","article-title":"Update on oral contraceptive pills and postcoital contraception","volume":"4","author":"Sondheimer","year":"1992","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"5","key":"10.14219\/jada.archive.1999.0173_bib103","first-page":"255","article-title":"The simultaneous use of rifampicin and other antitubercular agents with oral contraceptives","volume":"25","author":"Reimers","year":"1971","journal-title":"Prax Pneumol"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib104","first-page":"378","article-title":"Effects of rifampicin on the menstrual cycle and on estrogen excretion in patients taking oral contraceptives","volume":"226","author":"Noche-Finck","year":"1973","journal-title":"JAMA"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00002018-199309010-00003","article-title":"Oral contraceptives. Are drug interactions of clinical significance?","volume":"9","author":"Shenfield","year":"1993","journal-title":"Drug Safety"},{"issue":"5","key":"10.14219\/jada.archive.1999.0173_bib106","first-page":"31S","article-title":"Drug interactions with oral contraceptives: compilation and analysis of an adverse experience report data base","volume":"49","author":"Szoka","year":"1988","journal-title":"Fertil Steril"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib107","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0010-7824(80)90125-0","article-title":"The effect of rifampin on the pharmacokinetics of ethinylestradiol in women","volume":"21","author":"Back","year":"1980","journal-title":"Contraception"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib108","first-page":"193","article-title":"The effect of rifampin on norethisterone pharmacokinetics","volume":"15","author":"Back","year":"1979","journal-title":"Eur J Pharmacol"},{"issue":"5994","key":"10.14219\/jada.archive.1999.0173_bib109","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/bmj.4.5994.467-e","article-title":"Drug interaction with oral contraceptives","volume":"4","author":"Dossetor","year":"1975","journal-title":"Br Med J"},{"issue":"6210","key":"10.14219\/jada.archive.1999.0173_bib110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.280.6210.293","article-title":"Pregnancy attributable to interaction between tetracycline and oral contraceptives","volume":"280","author":"Bacon","year":"1980","journal-title":"Br Med J"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib111","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0015-0282(16)46350-8","article-title":"Possible interactions of antihistamines and antibiotics with oral contraceptive effectiveness","volume":"37","author":"DeSano","year":"1982","journal-title":"Fertil Steril"},{"issue":"5","key":"10.14219\/jada.archive.1999.0173_bib112","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0030-4220(86)90385-3","article-title":"Interaction between antibiotic therapy and contraceptive medication","volume":"61","author":"Bainton","year":"1986","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"5","key":"10.14219\/jada.archive.1999.0173_bib113","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2125.1988.tb03341.x","article-title":"Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics","volume":"25","author":"Back","year":"1988","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib114","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2230.1986.tb00471.x","article-title":"Interactions between oral contraceptive steroids and broad-spectrum antibiotics","volume":"11","author":"Orme","year":"1986","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib115","first-page":"392","article-title":"Reduced oral contraceptive effectiveness with concurrent antibiotic use: a protocol for prescribing antibiotics to women of childbearing age","volume":"9","author":"Donley","year":"1990","journal-title":"Compend Contin Educ Dent"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib116","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0190-9622(94)70127-X","article-title":"A practical approach to antibiotic treatment in women taking oral contraceptives","volume":"30","author":"Miller","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.14219\/jada.archive.1999.0173_bib117","first-page":"416","article-title":"The top 50 drugs dispensed by pharmacies in 1996","volume":"45","author":"Wynn","year":"1997","journal-title":"Gen Dent"},{"issue":"8","key":"10.14219\/jada.archive.1999.0173_bib118","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00007611-199108000-00012","article-title":"Oral contraceptive drug interactions: important considerations","volume":"84","author":"Fazio","year":"1991","journal-title":"South Med J"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib119","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0011-8532(22)00290-7","article-title":"Clinical implication of drugs taken by our patients","volume":"37","author":"Pyle","year":"1993","journal-title":"Dent Clin North Am"},{"issue":"12","key":"10.14219\/jada.archive.1999.0173_bib120","first-page":"79","article-title":"Antibiotic interference with oral contraceptives","volume":"122","year":"1991","journal-title":"JADA"},{"key":"10.14219\/jada.archive.1999.0173_bib121","first-page":"2027","article-title":"Ortho-Novum tablets (norethindrone\/ethinyl estradiol)","volume":"52","year":"1998"},{"issue":"2","key":"10.14219\/jada.archive.1999.0173_bib122","first-page":"82","article-title":"Wrongful birth and birth injury claims: new risks for oral surgeons","volume":"41","author":"Phiras","year":"1986","journal-title":"J Mass Dent Soc"},{"issue":"10","key":"10.14219\/jada.archive.1999.0173_bib123","first-page":"1228","article-title":"Drug interactions in dental practice: a summary of facts and controversies","volume":"15","author":"Becker","year":"1994","journal-title":"Compend Contin Educ Dent"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib124","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5694\/j.1326-5377.1986.tb128359.x","article-title":"Drug interactions with oral contraceptive preparations","volume":"144","author":"Shenfield","year":"1986","journal-title":"Med J Aust"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2230.1986.tb00471.x","article-title":"Interactions between oral contraceptive steroids and broad-spectrum antibiotics","volume":"11","author":"Orme","year":"1986","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib126","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF02340178","article-title":"Oral contraceptive steroids\u2014pharmacological issues of interest to the prescribing physician","volume":"7","author":"Orme","year":"1991","journal-title":"Adv Contracept"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib127","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0022-4731(78)90118-8","article-title":"The effect of antibiotics on the enterohepatic recirculation of ethinylestradiol and norhisterone in the rat","volume":"9","author":"Back","year":"1978","journal-title":"J Ster Biochem"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib128","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0022-4731(82)90053-X","article-title":"An antibiotic interaction with ethinyloestradiol in the rat and rabbit","volume":"16","author":"Back","year":"1982","journal-title":"J Steroid Biochem"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib129","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0002-9378(71)90803-9","article-title":"Reduced maternal plasma and urinary estriol during ampicillin treatment","volume":"109","author":"Willman","year":"1971","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0010-7824(80)90089-X","article-title":"A study of interaction of low-dose combination oral contraceptive with ampicillin and metronidazole","volume":"22","author":"Joshi","year":"1980","journal-title":"Contraception"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2125.1982.tb04932.x","article-title":"The effects of ampicillin on oral contraceptive steroids in women","volume":"14","author":"Back","year":"1982","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib132","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0002-9378(91)90617-Z","article-title":"The effect of tetracycline on levels of oral contraceptives","volume":"164","author":"Murphy","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib133","first-page":"416","article-title":"The effect of doxycycline on serum levels of ethinyl estradiol, norethindrone, and endogenous progesterone","volume":"77","author":"Neely","year":"1991","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib134","first-page":"81","article-title":"The interaction between clarithromycin and oral contraceptive steroids","volume":"2","author":"Back","year":"1991","journal-title":"J Pharm Med"},{"issue":"4","key":"10.14219\/jada.archive.1999.0173_bib135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0010-7824(91)90070-V","article-title":"The lack of interaction between temafloxacin and combined oral contraceptive steroids","volume":"43","author":"Back","year":"1991","journal-title":"Contraception"},{"key":"10.14219\/jada.archive.1999.0173_bib136","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1093\/clinids\/12.Supplement_3.S327","article-title":"Drug interactions with fluconazole","volume":"12","author":"Lazar","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib137","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0010-7824(83)80005-5","article-title":"The effect of cotrimoxazole on oral contraceptive steroids in women","volume":"28","author":"Grimmer","year":"1983","journal-title":"Contraception"},{"issue":"6","key":"10.14219\/jada.archive.1999.0173_bib138","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/clpt.1990.92","article-title":"A model to detect interactions between roxithromycin and oral contraceptives","volume":"47","author":"Meyer","year":"1990","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib139","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archderm.1994.01690030128027","article-title":"Frequency of pregnancy in acne patients taking oral antibiotics and oral contraceptives","volume":"130","author":"London","year":"1994","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.14219\/jada.archive.1999.0173_bib140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003088-199120010-00002","article-title":"Clinical pharmacokinetics of contraceptive steroids: an update","volume":"20","author":"Shenfield","year":"1991","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.14219\/jada.archive.1999.0173_bib141","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S1073110500004046","article-title":"California court denies wrongful birth claim","volume":"24","year":"1996","journal-title":"J Law Med Ethics"}],"container-title":["The Journal of the American Dental Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817714657184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002817714657184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T15:22:20Z","timestamp":1688916140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002817714657184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["S0002817714657184"],"URL":"https:\/\/doi.org\/10.14219\/jada.archive.1999.0173","relation":{},"ISSN":["0002-8177"],"issn-type":[{"value":"0002-8177","type":"print"}],"subject":[],"published":{"date-parts":[[1999,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADVERSE DRUG INTERACTIONS IN DENTAL PRACTICE","name":"articletitle","label":"Article Title"},{"value":"The Journal of the American Dental Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14219\/jada.archive.1999.0173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 American Dental Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}